Company Overview
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. It operates through two segments, Building Materials and Building Envelope. The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials. The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants. The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.
Why Investors Should Care
Net profit has compounded at 11.3% per year over the last five years.
Trades at a P/E of 18.8, below the sector median of 22.2.
Operating margin of 20.5% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $11.81B (+0.9% YoY); net profit $1.19B.
- Trailing 12 Months Year-on-year growth — revenue +8.6%, earnings +14.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.6%, profit CAGR 11.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.59% |
| 1 Year: | 8.60% |
Compounded Profit Growth
| 5 Years: | 11.33% |
| 1 Year: | 14.70% |
Stock Price Performance
| 1 Year: | -17.83% |
| 6 Months: | -27.91% |
| 3 Months: | -17.22% |
| 1 Month: | -9.84% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)33.81 · Neutral
P/E of 18.81 is below the sector median of 22.16 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 11.3% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 35.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AMRZ Amrize Ltd | 41.95 | 18.81 | $22.94B | 0.95% | 8.91% | 9.72% | 0.59% | 11.33% |
| 2 | LIN Linde plc NDXSPXR3K | 468.38 | 30.22 | $215.91B | 1.40% | 12.46% | 18.40% | 13.90% | 18.47% |
| 3 | SCCO Southern Copper Corporation R3K | 208.56 | 31.27 | $176.10B | 2.24% | 36.40% | 49.90% | 8.32% | 3.80% |
| 4 | NEM Newmont Corporation SPXR3K | 127.09 | 16.01 | $133.91B | 0.84% | - | 25.91% | 6.53% | 20.15% |
| 5 | RIO Rio Tinto Group | 103.83 | 14.07 | $130.27B | 4.78% | 13.65% | 19.31% | 1.24% | -7.00% |
| 6 | FCX Freeport-McMoRan Inc. SPXR3K | 76.62 | 37.56 | $110.03B | 0.78% | 12.50% | 14.75% | 1.35% | -1.26% |
| 7 | AEM Agnico Eagle Mines Limited | 201.84 | 17.27 | $102.20B | 0.88% | 19.78% | 22.97% | 27.53% | 88.11% |
| 8 | SHW The Sherwin-Williams Company SPXR3K | 326.09 | 30.05 | $79.16B | 1.00% | 21.93% | 65.12% | 6.18% | 8.26% |
| 9 | ECL Ecolab Inc. SPXR3K | 278.11 | 37.33 | $77.96B | 1.05% | 15.10% | 21.96% | 6.55% | 9.74% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 3.24B | 3.45B | 2.08B | 3.22B | 3.67B | 2.18B | 3.49B |
| Gross Profit | 979.00M | 1.04B | 222.00M | 966.00M | 1.09B | 211.00M | 993.00M |
| Operating Income | 754.00M | 844.00M | -16.00M | 669.00M | 778.00M | -76.00M | 711.00M |
| Net Income | 474.00M | 553.00M | -87.00M | 429.00M | 545.00M | -116.00M | 478.00M |
| Diluted EPS | 0.86 | 1.00 | -0.16 | 0.78 | 0.98 | -0.21 | 0.86 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 11.68B | 11.70B | 11.81B |
| Gross Profit | 2.77B | 3.07B | 3.03B |
| Operating Income | 1.89B | 2.19B | 1.91B |
| Net Income | 956.00M | 1.27B | 1.19B |
| Diluted EPS | 1.73 | 2.30 | 2.14 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | - | - | 23.80B | 24.25B |
| Total Equity | 8.21B | 9.20B | 9.91B | 13.26B |
| Cash & Equivalents | - | - | 1.58B | 1.92B |
| Total Liabilities | - | - | 13.89B | 10.99B |
| Current Liabilities | - | - | 2.55B | 2.86B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | 2.04B | 2.28B | 2.21B |
| Investing Cash Flow | -2.02B | -1.21B | -361.00M |
| Financing Cash Flow | 734.00M | -537.00M | -1.55B |
| Capital Expenditure | -630.00M | -642.00M | -788.00M |
| Free Cash Flow | 1.41B | 1.64B | 1.42B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 23.7% | 26.2% | 25.7% |
| Operating Margin % | 16.2% | 18.8% | 16.1% |
| Net Margin % | 8.2% | 10.9% | 10.0% |
| ROE % | 10.4% | 12.8% | 8.9% |
| ROCE % | - | 10.3% | 8.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Vanguard Capital Management LLC | 3.76% | 21.33M | $800.74M |
| 2 | Blackrock Inc. | 2.85% | 16.16M | $606.82M |
| 3 | NORGES BANK | 2.48% | 14.07M | $528.08M |
| 4 | Harris Associates L.P. | 2.47% | 13.99M | $525.22M |
| 5 | Zurcher Kantonalbank (Zurich Cantonalbank) | 1.91% | 10.85M | $407.23M |
| 6 | Invesco Ltd. | 1.52% | 8.59M | $322.55M |
| 7 | UBS Group AG | 1.46% | 8.26M | $310.04M |
| 8 | Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 1.33% | 7.55M | $283.27M |
| 9 | Vanguard Fiduciary Trust Co | 1.30% | 7.35M | $275.76M |
| 10 | Geode Capital Management, LLC | 1.10% | 6.21M | $233.05M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AMRZ
BofA downgrades Amrize to underperform, cuts price target on slower growth outlook
Investing.com -- Bank of America downgraded Amrize to Underperform from Neutral on Wednesday and cut its price target to $40 from $50, citing slower earnings growth, risks in key markets and a valuation it considers too full.…
Amrize Chief Strategy Officer Buys 2,510 Shares in $117,769 Transaction
Poletti's purchase expands his direct stake by 33%, signaling confidence from the strategic leader.
Billionaire Leon Cooperman Says Investors Are Acting Like ‘Pavlov’s Dog’ — Reveals 2 New Stock Picks
In a recent CNBC interview, Billionaire Leon Cooperman said that he has a negative view of the market amid a rising fiscal deficit and debt. The billionaire quoted Warren Buffett, who once said that the market sometimes reaches a point wher…
Amrize (AMRZ) Q2 2026 Earnings Call Transcript
Data center demand lifts cement and roofing volumes as oil inflation pressures margins.
Amrize's Q2 Earnings Miss, EBITDA Guidance Cut Raise Execution Concerns, RBC Capital Markets Says
Amrize's (AMRZ) Q2 earnings miss and reduced full-year adjusted EBITDA guidance showed weaker execut
Has Amrize (SWX:AMRZ) Fallen Far Enough To Look Undervalued?
Amrize stock has slipped year to date, yet the current market price still screens as cheap on the valuation checks. This sets up a clear question over whether the recent share price weakness is creating an opportunity or simply reflecting u…
AMRZ — Frequently Asked Questions
What is the current share price of Amrize Ltd (AMRZ)?
As of 2026-09-19 21:16 PDT, Amrize Ltd (AMRZ) trades at $41.95 on NYSE. Its 52-week range is $41.95 to $65.06.
What is the market capitalisation of AMRZ?
Amrize Ltd (AMRZ) has a market capitalisation of $22.94B on NYSE.
What is the P/E ratio of AMRZ?
AMRZ trades at a trailing price-to-earnings (P/E) ratio of 18.81. The industry average P/E is 22.16. Its price-to-book (P/B) ratio is 1.75.
Does AMRZ pay a dividend?
Amrize Ltd (AMRZ) currently offers a dividend yield of 0.95%.
What is the return on equity (ROE) of AMRZ?
AMRZ has a return on equity (ROE) of 9.72%. Its return on capital employed (ROCE) is 8.91%.
Is AMRZ a good stock to buy?
This page provides a data-driven analysis of Amrize Ltd (AMRZ), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.